Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: Characterization of sorafenib-resistant cells derived from a cutaneous metastasis-Reference-Cited by-同舟云学术

Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: Characterization of sorafenib-resistant cells derived from a cutaneous metastasis

Published:2013-02-04 Issue:9 Volume:20 Page:923-930
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Karashima Takashi¹,Fukuhara Hideo¹,Tamura Kenji¹,Ashida Shingo¹,Kamada Masayuki¹,Inoue Keiji¹,Taguchi Takahiro²,Kuroda Naoto³,Shuin Taro¹

Affiliation:

1. Department of Urology; Kochi University; Nankoku City; Japan

2. Department of Human Health and Medical Science; Faculty of Medicine; Kochi University; Nankoku City; Japan

3. Department of Pathology; Kochi Red Cross Hospital; Kochi City; Japan

Publisher

Wiley

Subject

Urology

Reference32 articles.

1. Renal cell carcinoma: presentation, staging, and surgical treatment;Russo;Semin. Oncol.,2000

2. Chemotherapy for renal cell carcinoma;Hartmann;Anticancer Res.,1999

3. Vaccine and gene therapy of renal cell carcinoma;Gitlitz;Semin. Urol. Oncol.,2001

4. Metastatic tumors of the skin;Brownstein;Cancer,1972

5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N. Engl. J. Med.,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Renal Cell Carcinoma Drug Resistance Models;Frontiers in Oncology;2022-05-10

2. Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma;Journal of Cancer;2022

3. The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma;British Journal of Cancer;2018-03-22

4. Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib;Cell Death & Disease;2017-10

5. A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207;Journal of Thoracic Oncology;2016-11